These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis]. Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511 [No Abstract] [Full Text] [Related]
15. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels. Speir RW; Calaway AC; Einhorn LH; Foster RS; Cary C Urol Oncol; 2020 Aug; 38(8):687.e19-687.e23. PubMed ID: 32448503 [TBL] [Abstract][Full Text] [Related]
16. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845 [TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649 [TBL] [Abstract][Full Text] [Related]
18. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series. Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780 [TBL] [Abstract][Full Text] [Related]
19. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer. Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479 [TBL] [Abstract][Full Text] [Related]
20. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients. Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]